Acorda Therapeutics Current Valuation vs. Gross Profit
ACORDelisted Stock | USD 16.20 0.40 2.41% |
For Acorda Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Acorda Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Acorda Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Acorda Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Acorda Therapeutics over time as well as its relative position and ranking within its peers.
Acorda |
Acorda Therapeutics Gross Profit vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Acorda Therapeutics's current stock value. Our valuation model uses many indicators to compare Acorda Therapeutics value to that of its competitors to determine the firm's financial worth. Acorda Therapeutics is rated third in current valuation category among its peers. It is rated second in gross profit category among its peers fabricating about 0.51 of Gross Profit per Current Valuation. The ratio of Current Valuation to Gross Profit for Acorda Therapeutics is roughly 1.96 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Acorda Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Acorda Current Valuation vs. Competition
Acorda Therapeutics is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 14.53 Billion. Acorda Therapeutics claims roughly 161.45 Million in current valuation contributing just under 2% to equities under Health Care industry.
Acorda Gross Profit vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Acorda Therapeutics |
| = | 161.45 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Acorda Therapeutics |
| = | 82.43 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Acorda Gross Profit Comparison
Acorda Therapeutics is currently under evaluation in gross profit category among its peers.
Acorda Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Acorda Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Acorda Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Acorda Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Acorda Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Acorda Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.
Acorda Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Acorda Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Acorda Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Acorda Therapeutics' important profitability drivers and their relationship over time.
Use Acorda Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acorda Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acorda Therapeutics will appreciate offsetting losses from the drop in the long position's value.Acorda Therapeutics Pair Trading
Acorda Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Acorda Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acorda Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acorda Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acorda Therapeutics to buy it.
The correlation of Acorda Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acorda Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acorda Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acorda Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Acorda Therapeutics position
In addition to having Acorda Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Directory Find actively traded commodities issued by global exchanges |